搜尋結果
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's ...
CNBC· 2 日前The Food and Drug Administration on Friday expanded the approval of GSK's respiratory ...
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 3 日前A 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long ...
Opioid Deaths May Have Peaked. Demand-Side Policies Could Be Working
Forbes· 5 日前The steepest rise in annual overdose deaths occurred from around 2012 to 2021, as the graph ...
FDA panel to review psychedelic drug MDMA for first time
Reuters· 6 日前The meeting by the agency's independent experts is the farthest that a drug based ... ...
CNBC Daily Open: GameStop can't stop, Dow drops
CNBC· 6 日前A screen displays the logo and trading information for GameStop on the floor of the New York ...